These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 937905)

  • 1. Treatment of recurrent symptomatic ventricular tachycardia.
    Winkle RA; Alderman EL; Fitzgerald JW; Harrison DC
    Ann Intern Med; 1976 Jul; 85(1):1-7. PubMed ID: 937905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.
    Mason JW; Winkle RA
    Circulation; 1978 Dec; 58(6):971-85. PubMed ID: 709781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic prophylaxis in ambulatory patients with coronary heart disease.
    Koch-Weser J
    Arch Intern Med; 1972 May; 129(5):763-72. PubMed ID: 4554558
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
    Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM
    Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac arrhythmias. Rationale of drug therapy.
    Chung EK
    Singapore Med J; 1973 Sep; 14(3):325-33. PubMed ID: 4591402
    [No Abstract]   [Full Text] [Related]  

  • 6. Procainamide in the induction and perpetuation of ventricular tachycardia in man.
    Kang PS; Gomes JA; El-Sherif N
    Pacing Clin Electrophysiol; 1982 May; 5(3):311-22. PubMed ID: 6179048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta blockers in combination with class I antiarrhythmic agents.
    Deedwania PC; Olukotun AY; Kupersmith J; Jenkins P; Golden P
    Am J Cardiol; 1987 Aug; 60(6):21D-26D. PubMed ID: 2442991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic basis for the treatment of cardiac arrhythmias.
    Gelband H; Rosen MR
    Pediatrics; 1975 Jan; 55(1):59-67. PubMed ID: 1089243
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiarrhythmic drug therapy for sporadic ventricular ectopic arrhythmias.
    Jelinek MV; Lohrbauer L; Lown B
    Circulation; 1974 Apr; 49(4):659-66. PubMed ID: 4817707
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term tocainide therapy for ventricular arrhythmias.
    Winkle RA; Meffin PJ; Harrison DC
    Circulation; 1978 May; 57(5):1008-16. PubMed ID: 639200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic and hemodynamic evaluation of indecainide and procainamide in nonsustained ventricular tachycardia.
    Pratt CM; Francis MJ; Seals AA; Zoghbi W; Young JB
    Am J Cardiol; 1990 Jul; 66(1):68-74. PubMed ID: 2193498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological therapy and prevention of recurrent ventricular tachycardia].
    Vajola SF; Chiavarelli V; Milazzotto F
    G Ital Cardiol; 1981; 11(11):1743-9. PubMed ID: 7343378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistant ventricular tachycardias and recurrent cardiac arrests. 96 episodes.
    Harner RH; Boyd RB
    Chest; 1977 Mar; 71(3):426-9. PubMed ID: 837764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug therapy of arrhythmias].
    Bender F; Schmidt E; Gradaus D
    Schweiz Med Wochenschr; 1969 Oct; 99(43):1539-42. PubMed ID: 5362117
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristics of ventricular tachycardia in ambulatory patients.
    Winkle RA; Derrington DC; Schroeder JS
    Am J Cardiol; 1977 Apr; 39(4):487-92. PubMed ID: 557893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of procainamide and quinidine for better tolerance and additive effects for ventricular arrhythmias.
    Kim SG; Seiden SW; Matos JA; Waspe LE; Fisher JD
    Am J Cardiol; 1985 Jul; 56(1):84-8. PubMed ID: 4014046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmogenic ventricular aneurysms unrelated to coronary artery disease.
    Rajasinghe HA; Lorenz HP; Longaker MT; Scheinman MM; Merrick SH
    Ann Thorac Surg; 1995 May; 59(5):1079-84. PubMed ID: 7733701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: comparison of propranolol, procainamide and quinidine.
    Winkle RA; Gradman AH; Fitzgerald JW
    Am J Cardiol; 1978 Sep; 42(3):473-80. PubMed ID: 685858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.